Electroacupuncture at the ST36 point restored gastric motility in diabetic rats by activating a nerve circuit from the acupuncture site through the spinal cord and brainstem to the stomach, regulating key gastrointestinal peptides including gastrin, motilin, and VIP.
Vagotomy abolished all benefitsCutting the vagus nerve below the diaphragm completely eliminated electroacupuncture's improvements in gastric motility and cell recovery, proving this nerve pathway is essential.
What the researchers found
Electroacupuncture at ST36 significantly increased gastric emptying rate, restored stomach slow-wave rhythms, and improved smooth muscle architecture in diabetic gastroparesis rats. The treatment reduced inflammatory infiltration and increased expression of nNOS, C-kit, and SCF — markers of healthy stomach nerve and muscle function.
The mechanism was mapped to a specific neural circuit: electroacupuncture activated vagal targets (ChAT and α7nAChR) at the stimulation site, sending signals through spinal segments L4-L6 to the nucleus tractus solitarius (NTS) in the brainstem, which then regulated gastrointestinal peptides (gastrin, motilin, and vasoactive intestinal peptide) and restored interstitial cells of Cajal function via vagal efferent pathways.
Critically, subdiaphragmatic vagotomy completely abolished the electroacupuncture-induced improvements in gastric motility and ICC recovery, confirming the vagus nerve is indispensable to this therapeutic effect.
Why it matters
Diabetic gastroparesis affects a significant proportion of diabetes patients and has limited treatment options. This study provides a detailed molecular map of how electroacupuncture may improve stomach function, moving acupuncture research from observational claims to mechanistic understanding. The identification of specific peptide targets (gastrin, motilin, VIP) in this pathway could inform future drug development.
How the study worked
Researchers induced diabetic gastroparesis in rats using a single high-dose injection of streptozotocin combined with 8 weeks of a high-sugar, high-fat diet. They then compared electroacupuncture at ST36 against pharmacological interventions (ChAT agonist and inhibitor) and subdiaphragmatic vagotomy. Outcomes were assessed using phenol red gastric emptying assays, slow-wave recordings, PET-CT imaging, histopathological analysis, Western blot, immunofluorescence, and ELISA for gastrointestinal peptides.
What this study cannot tell us
This was an animal study in rats, so the results may not directly translate to humans. The diabetic gastroparesis model was chemically induced, which may not fully replicate the gradual nerve damage seen in human diabetes. The study does not report specific sample sizes per group in the abstract, and no behavioral or quality-of-life outcomes were measured. Long-term effects of the treatment were not assessed.
How to read the evidence
This is a preclinical animal study using a rat model of diabetic gastroparesis. While the experimental design is rigorous with multiple outcome measures and a vagotomy control, findings in rats require validation in human clinical trials.
When this study was published
Published in 2025, this is very recent research that applies modern molecular techniques to understand electroacupuncture mechanisms in gastrointestinal disease.
The bigger picture
This study contributes to the growing body of research seeking to understand acupuncture through modern neuroscience. By mapping the precise neural circuit from peripheral stimulation through the brainstem to gut peptide regulation, it bridges traditional Chinese medicine with molecular biology. The findings also add to our understanding of the gut-brain axis and how peripheral nerve stimulation can modulate gastrointestinal peptide signaling.
Questions still open
- Would electroacupuncture at ST36 produce similar gastric motility improvements in human patients with diabetic gastroparesis?
- Could pharmacological agents targeting the same ChAT/α7nAChR/NTS pathway achieve similar results without acupuncture?
- How do the changes in gastrin, motilin, and VIP levels correlate with symptom relief in gastroparesis patients?
Common questions
What is diabetic gastroparesis and why is it hard to treat?
How does electroacupuncture differ from traditional acupuncture?
Read the original research
Electroacupuncture at ST36 ameliorates gastric dysmotility in rats with diabetic gastroparesis via the nucleus tractus solitarius-vagal axis.
World journal of gastroenterology, 31(21), 107395
Citation
Zhang, You; Tang, Yi-Wen; Zhou, Jin; Wei, Yan-Rong; Peng, Yu-Ting; Yan, Zi; Yue, Zeng-Hui. (2025). Electroacupuncture at ST36 ameliorates gastric dysmotility in rats with diabetic gastroparesis via the nucleus tractus solitarius-vagal axis.. World journal of gastroenterology, 31(21), 107395. https://doi.org/10.3748/wjg.v31.i21.107395